Mitochondrial-Targeted SS-31 Attenuates the Doxorubicin-Induced Cardiomyoblast H9C2 Cell Senescence

Jiaojiao Fan, Jinzi Wu, Shuo Yan, Songlin Li, Peter S. Rabinovitch, Xingyun Qi, Huiliang Zhang · 2026

Read Mitochondrial-Targeted SS-31 Attenuates the Doxorubicin-Induced Cardiomyoblast H9C2 Cell Senescence by Jiaojiao Fan, Jinzi Wu, Shuo Yan, Songlin Li, Peter S. Rabinovitch, Xingyun Qi, Huiliang Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13359912.txt.

Description

Jiaojiao Fan and co-authors build a cell model of chemotherapy heart damage in a 2026 study. Doxorubicin cures many cancers but can age heart cells early, a process called senescence that limits the drug's use. The team exposed rat heart muscle cells, H9C2, to a low dose of the drug and produced a stable senescence model with clear aging markers and faulty mitochondria.

They then tested SS-31, a compound that targets mitochondria. It reversed key aging signs and lowered cell stress in the model. The setup gives drug hunters a reliable screen for heart-protective candidates, and SS-31 itself emerges as a promising shield.

Catalog record

CREATORJiaojiao Fan, Jinzi Wu, Shuo Yan, Songlin Li, Peter S. Rabinovitch, Xingyun Qi, Huiliang Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30231
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13359912

Browse the full library · About the Tower of Babel